Teriflunomide Tablet
Product Images NDC 69339-169

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Teriflunomide (NDC 69339-169). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Natco Pharma Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Teriflunomide-figure-1 (Teriflunomide Figure 1)

A line graph comparing disability progression sustained over 12 weeks (%) for placebo versus 7 mg and 14 mg teriflunomide tablets over 108 weeks. The graph includes a legend identifying each group and a table of numbers at risk below the x-axis representing weeks. The 14 mg teriflunomide line shows statistically significant differences versus placebo (p < 0.05).*

FDA Label Image

Teriflunomide-figure-2 (Teriflunomide Figure 2)

A line graph showing disability progression sustained for 12 weeks (%) over time (weeks) comparing placebo, 7 mg teriflunomide tablets, and 14 mg teriflunomide tablets. The vertical axis represents disability progression percentage, and the horizontal axis indicates weeks up to 108. Lines illustrate increasing progression percentages for each group, with 14 mg teriflunomide showing a statistically significant difference compared to placebo (p < 0.05). A table below the graph shows the number of subjects at risk for each group at various time points.*

FDA Label Image

Structure (Teriflunomide Structure)

Chemical structure of teriflunomide, showing its molecular framework with a trifluoromethyl-substituted aromatic ring, an amide linkage, and a cyano group attached to an unsaturated carbonyl structure.*

FDA Label Image

Inner-carton (Teriflunomide Tablets Wallet Inner Carton 14mg)

Packaging label for Teriflunomide Tablets 14 mg oral tablets by Natco Pharma USA LLC. The label includes a blister card with day markings for tablet tracking, dosage instructions indicating one tablet daily, storage temperature guidance, and manufacturer information for Dash Pharmaceuticals LLC and Natco Pharma Limited, India. The design features teal and gray color blocks and a barcode.*

FDA Label Image

Inner-carton (Teriflunomide Tablets Wallet Inner Carton 7mg)

Packaging label for Teriflunomide Tablets 7 mg oral tablets by Natco Pharma USA LLC. The carton displays the brand and generic name, strength (7 mg per tablet), tablet count visualization, dosing schedule circles for 31 days, manufacturer's information including Natco Pharma Limited, India, and DASH Pharmaceuticals, USA, and storage instructions.*

FDA Label Image

Wallet-carton-14mg (Teriflunomide Tablets Wallet Outer Carton 14mg)

Packaging label for Teriflunomide Tablets 14 mg oral tablets by Natco Pharma USA LLC. The label indicates a carton containing 30 unit-dose tablets (2x15). It includes usage instructions, storage conditions, and manufacturer information for Natco Pharma Limited, India, and DASH Pharmaceuticals LLC, USA.*

FDA Label Image

Outer-carton (Teriflunomide Tablets Wallet Outer Carton 7mg)

Packaging label for Teriflunomide Tablets 7 mg oral tablets, containing 30 unit-dose tablets (2x15). The label indicates prescription use (Rx only), includes a NDC number (69339-169-93), and displays logos for DASH Pharmaceuticals and Natco. Instructions for opening and closing the carton securely are printed on the inner flap. Storage and warning information is also included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.